Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
394,240
-
Share change
-
+105,784
-
Total reported value
-
$3,921,376
-
Price per share
-
$9.96
-
Number of holders
-
9
-
Value change
-
+$1,051,377
-
Number of buys
-
8
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2014
As of 31 Dec 2014,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
394,240 shares.
The largest 9 holders included
Krasney Financial LLC, AMERICAN INTERNATIONAL GROUP INC, GLENMEDE TRUST CO NA, NEW ENGLAND SECURITIES CORP /MA/, HARDESTY CAPITAL MANAGEMENT CORP, BANK OF AMERICA CORP /DE/, Hoxton Financial, Inc., ROYAL BANK OF CANADA, and PNC Financial Services Group, Inc..
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.